Highbridge Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-9,920
| Closed | -$1.38M | – | 480 |
|
|
2018
Q3 | $1.38M | Sell |
9,920
-999
| -9% | -$139K | 0.03% | 294 |
|
|
2018
Q2 | $1.36M | Sell |
10,919
-58,136
| -84% | -$7.21M | 0.03% | 344 |
|
|
2018
Q1 | $7.7M | Sell |
69,055
-107,118
| -61% | -$11.9M | 0.12% | 154 |
|
|
2017
Q4 | $21.1M | Buy |
176,173
+174,168
| +8,687% | +$20.8M | 0.38% | 35 |
|
|
2017
Q3 | $281K | Sell |
2,005
-126,836
| -98% | -$17.8M | ﹤0.01% | 648 |
|
|
2017
Q2 | $15.7M | Sell |
128,841
-104,522
| -45% | -$12.7M | 0.23% | 84 |
|
|
2017
Q1 | $28.3M | Buy |
233,363
+190,757
| +448% | +$23.1M | 0.41% | 33 |
|
|
2016
Q4 | $5.21M | Buy |
+42,606
| New | +$5.21M | 0.09% | 215 |
|
|
2016
Q3 | – | Sell |
-115,363
| Closed | -$13.5M | – | 1430 |
|
|
2016
Q2 | $13.5M | Buy |
115,363
+60,770
| +111% | +$7.1M | 0.22% | 113 |
|
|
2016
Q1 | $7.6M | Buy |
+54,593
| New | +$7.6M | 0.13% | 172 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1204 |
|
|
2015
Q2 | – | Sell |
-193,270
| Closed | -$33.5M | – | 1155 |
|
|
2015
Q1 | $33.5M | Buy |
193,270
+189,561
| +5,111% | +$32.9M | 0.46% | 49 |
|
|
2014
Q4 | $686K | Sell |
3,709
-2,287
| -38% | -$423K | 0.01% | 512 |
|
|
2014
Q3 | $994K | Buy |
+5,996
| New | +$994K | 0.01% | 517 |
|
|
2013
Q4 | – | Sell |
-131,941
| Closed | -$15.3M | – | 1029 |
|
|
2013
Q3 | $15.3M | Sell |
131,941
-66,855
| -34% | -$7.77M | 0.16% | 169 |
|
|
2013
Q2 | $18.3M | Buy |
+198,796
| New | +$18.3M | 0.18% | 137 |
|